Predicting Survival in Pulmonary Arterial Hypertension
Raymond L. Benza(Triangle), Michael D. McGoon(Mayo Clinic in Arizona)
Cited by 1,548
Related Papers
Valvular Heart Disease Associated with Fenfluramine–Phentermine
|New England Journal of Medicine|1997|1.6k
Primary pulmonary hypertension: natural history and the importance of thrombosis.
|Circulation|1984|1.1k
Clinical risk factors for portopulmonary hypertension†
|Hepatology|2008|286
Genetic Risk Factors for Portopulmonary Hypertension in Patients with Advanced Liver Disease
|American Journal of Respiratory and Critical Care Medicine|2009|232
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis
|The Lancet Respiratory Medicine|2018|212